Showing results (371-380 of 379) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 379 results.
Arthritis and Rheumatism|April 9, 2005
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy studyJ S Smolen, C Han, M Bala, et al.
Arthritis and Rheumatism|May 1, 1993
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators GroupV Strand, P E Lipsky, G W Cannon, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Infliximab in active early rheumatoid arthritisF C Breedveld, P Emery, E Keystone, et al.
Annals of the Rheumatic Diseases|April 12, 2006
The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosusG Oroszi, L Lapteva, E Davis, et al.
Cell Transplantation|March 7, 1998
Blockade of CD40-CD154 interferes with human T cell engraftment in scid miceT M Foy, M McIlraith, S R Masters, et al.
JAMA|December 2, 1999
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trialL S Simon, A L Weaver, D Y Graham, et al.
Arthritis and Rheumatism|April 13, 2004
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateR N Maini, F C Breedveld, J R Kalden, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Pageof 38